LINC02520
gene geneOn this page
Summary
LINC02520 (long intergenic non-protein coding RNA 2520, HGNC:53511) is a long non-coding RNA gene on chromosome 6p21.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53511 |
| Approved symbol | LINC02520 |
| Name | long intergenic non-protein coding RNA 2520 |
| Location | 6p21.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000204110 |
| Ensembl biotype | lncRNA |
| Entrez | 100505530 |
| RNAcentral | URS00007E386E — lncRNA, 1201 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000414875, ENST00000570443, ENST00000656831, ENST00000689244, ENST00000690655, ENST00000829675, ENST00000829676, ENST00000829677, ENST00000831050
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000414875 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001614320 | 37550568 | 37550860 |
| ENSE00001651931 | 37549978 | 37550152 |
| ENSE00002649123 | 37546155 | 37546245 |
| ENSE00002655441 | 37545145 | 37545413 |
| ENSE00002668644 | 37549046 | 37549215 |
Expression profiles
Bgee: expression breadth broad, 98 present calls, max score 74.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0538 / max 22.1307, expressed in 18 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 67646 | 0.0538 | 18 |
Top tissues by expression
98 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.95 | gold quality |
| lymph node | UBERON:0000029 | 71.46 | gold quality |
| ganglionic eminence | UBERON:0004023 | 68.37 | gold quality |
| duodenum | UBERON:0002114 | 67.35 | gold quality |
| leukocyte | CL:0000738 | 67.27 | gold quality |
| tonsil | UBERON:0002372 | 65.12 | gold quality |
| blood | UBERON:0000178 | 62.26 | gold quality |
| vermiform appendix | UBERON:0001154 | 62.18 | gold quality |
| bone marrow cell | CL:0002092 | 60.69 | silver quality |
| urinary bladder | UBERON:0001255 | 58.48 | gold quality |
| granulocyte | CL:0000094 | 57.47 | gold quality |
| islet of Langerhans | UBERON:0000006 | 55.94 | gold quality |
| small intestine | UBERON:0002108 | 55.83 | gold quality |
| gall bladder | UBERON:0002110 | 55.29 | gold quality |
| liver | UBERON:0002107 | 53.66 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 53.63 | gold quality |
| prefrontal cortex | UBERON:0000451 | 53.52 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 53.47 | gold quality |
| substantia nigra | UBERON:0002038 | 53.39 | gold quality |
| cortex of kidney | UBERON:0001225 | 52.37 | gold quality |
| muscle of leg | UBERON:0001383 | 52.22 | gold quality |
| right lobe of liver | UBERON:0001114 | 52.15 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 51.90 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 51.54 | gold quality |
| spleen | UBERON:0002106 | 51.44 | gold quality |
| kidney | UBERON:0002113 | 50.97 | gold quality |
| fallopian tube | UBERON:0003889 | 50.82 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 50.59 | gold quality |
| intestine | UBERON:0000160 | 50.54 | gold quality |
| hypothalamus | UBERON:0001898 | 50.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.93 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.